Separate Ownership Voice from Innovation Authority: A Family-Office Allocation Protocol Family Office Private Wealth Journal · Editorial research desk Family Office Private Wealth Journal · 2026-11-18 CC BY 4.0 · https://creativecommons.org/licenses/by/4.0/ Source: https://journal.research.university/journals/family-office-private-wealth/articles/expansion-10-3390-su14148418-solutions Abstract A source-bounded protocol for family offices that oversee operating companies and must allocate innovation capital amid concentrated ownership, differing family preferences and imperfect evidence. It separates ownership voice from delegated authority, distinguishes product and process innovation, requires independent challenge and reversible pilots, and stops deployment when authority, conflicts, evidence or liquidity cannot be reconciled. 1. Use the study as a decision prompt, not a family-office rule Wei and Chen analyze 882 Chinese small- and medium-sized family firms in the 2015 All-China Federation of Industry and Commerce survey. They distinguish product innovation input from process innovation input and report associations between intra-family ownership concentration and the relative allocation to those two categories. They also examine whether the proportion of family directors and a collective decision-making mode moderate those relationships. The design is cross-sectional and studies family firms, not family offices, investment funds, trusts, foundations or a governance intervention. The source therefore cannot tell a family office how much innovation capital to deploy, which project will perform, or whether changing voting rights will cause a better outcome. It does not test the protocol below. Its useful prompt is narrower: ownership, board composition, decision mode and innovation category may be entangled, so an office should make each element visible before approving capital. This companion is AI-assisted editorial analysis; the source authors did not design, test or endorse it. 2. Map ownership voice and lawful decision authority The family council chair and governance secretary create an ownership-and-authority map for every operating company within the office's authorized scope. The map identifies legal owners, beneficial interests, voting rights, reserved matters, board seats, committee mandates, delegated executives, minority protections, conflicts and the governing document that supports each decision right. It distinguishes a person's economic interest, advisory voice, board duty and executive authority. A family member may hold several roles, but the record states which role is being exercised in each decision. The map includes a dated issue log for unclear delegations, inconsistent documents, side agreements, disputed ownership, related-party interests and decisions that require consent beyond the family office. An ownership percentage is not treated as permission to direct an operating company outside its governing documents. Likewise, collective discussion is not recorded as approval unless the authorized body reaches the required decision. Legal and tax questions are referred to separately authorized professionals; the map records their scope and qualifications rather than implying clearance. 3. Split the innovation thesis before splitting the budget The operating-company innovation lead writes two separate theses: one for product innovation and one for process innovation. Each identifies the customer or operating problem, expected mechanism, current evidence, alternatives, dependencies, intellectual-property and data considerations, time horizon, cash requirement, reversibility and the loss the entity can absorb. A project that contains both categories states which assumptions and milestones belong to each. The categories are planning aids, not claims that every activity fits neatly into one box. The chief financial officer links each thesis to the entity's approved capital plan, liquidity floor and funding authority. The office records whether capital is equity, debt, grant, intercompany funding or another instrument; who bears downside; what rights attach to the funding; and which obligations remain legally separate. It does not import coefficients, averages or significance levels from the source study as investment thresholds. The innovation allocation memorandum states the family objectives and enterprise objectives that are relevant, and records any conflict between them rather than collapsing both into a single label such as long-term value. 4. Challenge concentration without manufacturing consensus An independent challenger who did not originate the proposal tests the authority map and both innovation theses. The challenger asks whether a concentrated owner is turning influence into an undocumented instruction, whether a broad family group is creating delay without accountability, whether family directors face duties that differ from family preferences, and whether process improvements are being underfunded because product launches are more visible. The challenge includes one credible alternative allocation and one adverse scenario for each category. The decision chair uses a written sequence: disclose interests, confirm the authorized body, circulate evidence, record questions and dissent, obtain any required professional review, and decide approve, approve with conditions, pilot, defer or reject. Collective decision making is documented as a method, including who participated, whose consent was required and how deadlock is handled. It is not described as inherently superior. Dissent remains in the record, and no family member or employee may be penalized for raising a documented authority, conflict, safety or evidence concern through the approved channel. 5. Run paired, reversible pilots and measure learning Where feasible, the board authorizes one bounded product pilot and one bounded process pilot rather than committing the full portfolio at once. Each pilot has an owner, budget ceiling, start and stop date, data source, milestone, decision rule and named person responsible for learning capture. Product measures may include validated customer need, adoption, defect or safety signals and unit economics. Process measures may include cycle time, error rate, reliability, employee burden and control failures. The office pre-specifies which measures are exploratory and which can trigger further capital. Governance measures remain separate from commercial outcomes: time from complete memorandum to decision; unresolved authority exceptions; disclosed conflicts; concentration of approvals; proportion of decisions with independent challenge; changes made after challenge; milestone evidence submitted on time; and decisions stopped for missing authority or evidence. A successful launch does not excuse a governance breach, and a stopped pilot is not automatically a failure if it prevented larger loss. The office compares results with its own stated baseline and records unintended effects, because the source study does not validate these controls or prove that they improve returns. 6. Stop on ambiguity and close with a reproducible record Pause allocation when the legal owner, approving authority, reserved matter, funding instrument, conflict, intellectual-property right, data permission, regulatory requirement or liquidity effect cannot be reconciled. Stop a pilot when it breaches its loss limit, produces a pre-specified safety or control signal, depends on data that cannot be lawfully used, requires an undisclosed related-party transaction, or continues after the authorized body withdraws approval. Stop the process itself if records are altered outside version control, dissent is suppressed, evidence is fabricated, or an informal instruction is substituted for the required approval. The governance secretary closes each case with a dated decision record containing the authority map version, ownership interests, category thesis, evidence, alternatives, challenge, conflicts, vote or consent, conditions, pilot results, deviations and next review date. The record separates source-study findings, external professional opinions, internal estimates and committee judgment. The final status is approve, conditional approval, pilot complete, defer, reject, remediate or refer. Automated license, hash, passage and abstention tests establish publication provenance for this source and companion; they do not constitute human peer review, investment advice, legal clearance or evidence that the protocol improved a family office's outcomes. Source, attribution and limits [1] Xiao Wei; Ling Chen. Dispersion of Family Ownership and Innovation Input in Family Firms. Sustainability (2022-07-09). https://doi.org/10.3390/su14148418. CC BY 4.0. The cross-sectional study uses a 2015 survey sample of 882 Chinese small- and medium-sized family firms, not family offices, investment funds, trusts, foundations, beneficiaries or a capital-allocation intervention. Self-reported survey measures, category construction, one-country and one-period context, observational associations and the authors' stated inability to evaluate time-series change prevent causal, performance or family-office inference. The proposed protocol was not tested by the source study. Prepared by the Family Office Private Wealth Journal editorial research desk with AI assistance at the direction of Dr. Freedom Cheteni. Original research authors retain full credit and are not authors or endorsers of this companion. This proposed process has not been evaluated in a new empirical study; no independent peer-review acceptance is claimed. This is educational analysis, not individualized investment, legal or tax advice. Rights: © 2026 The Research University. © 2026 The Research University. This original editorial text is licensed Creative Commons Attribution 4.0 International. Attribute the title, editorial research desk and publisher, link to the license and indicate changes. Underlying research, talks and recordings retain their separate attribution and rights. Edition changes: Original AI-assisted editorial synthesis. Research findings, transcript themes and proposed practices remain distinct. No new participant data or independent peer-review acceptance is claimed.